Loading the section…

STIM: financial statements from SEC — TradeAlmanac

STIM

Neuronetics, Inc.: financial statements

Company reports as filed with the U.S. Securities and Exchange Commission.

AnnualQuarterly

Income statement

Metric	31/12/2025	31/12/2024
Revenue	149M	75M
Cost of revenue	77M	21M
Gross profit	72M	54M
Research and development	7M	13M
Selling, general and administrative	50M	30M
Operating expenses	104M	89M
Operating income	−31M	−35M
Interest expense	—	7M
Net income	−39M	−44M
Earnings per share	−0.59	−1.38
Earnings per share, diluted	−0.59	−1.38
Weighted average shares	66M	32M
Weighted average shares, diluted	66M	32M

Balance sheet

Metric	31/03/2026	31/12/2025	30/09/2025	30/06/2025	31/03/2025	31/12/2024	30/09/2024	30/06/2024
Cash and equivalents	13M	28M	28M	11M	20M	18M	21M	43M
Receivables	16M	16M	19M

Cash flow

Metric	31/12/2025	31/12/2024
Operating cash flow	−20M	−31M
Depreciation and amortisation	3M	2M
Share-based compensation	7M	6M
Capital expenditure	801,000	1M
Investing cash flow	−801,000	−2M
Financing cash flow	36M

Amounts in USD unless stated otherwise. Data: US exchange trading and company filings with the regulator